Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	30.64	-247.32	-356.59
Graham Fair Price	19.01	4.81	4.04
PEG	-50.77	-1.02	2.07
Price/Book	-4.26	6.80	7.10
Price/Cash Flow	52.39	-109.39	71.78
Prices/Earnings	35.09	-47.05	-72.49
Price/Sales	19.65	41.36	34.56
Price/FCF	52.39	-109.39	71.78
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.72	0.42	0.41
Operating Margin	-61.31	-0.20	-0.12
ROA	-57.56	-0.03	-0.02
ROE	-0.02	-0.04	-47.50
ROIC	-0.03	-0.03	-3.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.09	-52.94
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.35	-0.27	-23.62
EPS QOQ	0.35	-0.46	31.87
FCF QOQ	2.40	-1.62	-32.50
Revenue QOQ	0.39	-0.21	-45.01
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	67.51	61.57	-8.80
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.03	0.02	-2.35
Quick Ratio	1.67	2.04	21.96
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.45	5.34	-2.01
Cash	1.92	1.79	-6.48
Capex	< 0.005	< 0.005	1.30
Free Cash Flow	0.54	-0.33	-38.43
Revenue	1.12	0.88	-21.59
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.90	2.35	23.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.11	6.72	-33.60
Naive Interpretation	Member

06 - Financial Health · Bad

Rating